pembrolizumab
merck
['keynote-412', 'head and neck', 'pembro']
pimary results of the phase iii keynote-412 study: pembrolizumab (pembro) with chemoradiation therapy (crt) vs placebo plus crt for locally advanced (la) head and neck squamous cell carcinoma (hnscc) #esmo2022 
Medicina Interna - Oncología Clínica - Profesor Titular @UPBColombia - Clínica Astorga. #Medellín / #Colombia mlujanonco@gmail.com #OncTwitter #Metaanalysis